Aripiprex 10 mg 20 tablets

Tradename

Aripiprex

Aripiprex

Compound:

Each tablet contains:

Aripiprazole 10mg

Auxiliary components:

lactose monohydrate, microcrystalline cellulose, corn starch, hyprolose, croscarmellose sodium, magnesium stearate, iron oxide yellow dye.

Properties

Antipsychotic (neuroleptic). It is assumed that the therapeutic effect of aripiprazole in schizophrenia is due to a combination of partial agonistic activity against dopamine D2- and serotonin 5-HT1a receptors and antagonistic activity against serotonin 5-HT2 receptors.

Aripiprazole has high affinity in vitro for dopamine D2- and D3-receptors, serotonin 5-HT1a- and 5-HT2a-receptors and moderate affinity for dopamine D4-, serotonin 5-HT2c- and 5-HT7-, α1-adrenergic receptors and histamine H1 receptors. Aripiprazole is also characterized by moderate affinity for serotonin reuptake sites and no affinity for muscarinic receptors.

Indications

Treatment of acute attacks of schizophrenia, maintenance therapy of schizophrenia.

Treatment of acute manic episodes of bipolar I disorder and for maintenance therapy in patients with bipolar I disorder who have recently experienced a manic or mixed episode.

Dosage and administration

The method of application and dosing regimen of a particular drug depends on its form of release and other factors. The optimal dosing regimen is determined by the doctor. Compliance of the dosage form of a particular drug with indications for use and dosing regimen should be strictly observed.

Individual, depending on the indications, the course of the disease, tolerability of therapy. The dose is 10-30 mg 1 time / day.

Contraindications

Senile dementia, lactation period, children and adolescents under 18 years of age, hypersensitivity to aripiprazole.

Precautionary measures:

Use with caution in patients with cardiovascular diseases (CHD, including myocardial infarction, chronic heart failure, conduction disturbances), conditions predisposing to arterial hypotension (dehydration, hypovolemia and taking antihypertensive drugs) due to the possibility of developing orthostatic hypotension; in patients with cerebrovascular diseases, with convulsive seizures or suffering from diseases in which convulsions are possible; in patients with an increased risk of hyperthermia (for example, with intense physical exertion, overheating, taking anticholinergic drugs, with dehydration due to the ability of antipsychotics to disrupt thermoregulation); in patients with an increased risk of aspiration pneumonia due to the risk of impaired motor function of the esophagus and aspiration; in patients with obesity, with a history of diabetes mellitus; taking funds with m-anticholinergic activity.

Side effects

From the side of the cardiovascular system: often — orthostatic hypotension, tachycardia; possibly — bradycardia, palpitations, myocardial infarction, prolongation of the QT interval, cardiac arrest, hemorrhage, atrial fibrillation, heart failure, AV blockade, myocardial ischemia, deep vein thrombosis, phlebitis, extrasystole; rarely — vasovagal syndrome, heart enlargement, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral ischemia.

Storage method:

In a dry cool place at a temperature not exceeding 30 degrees.